AGTR1 and endothelial dysfunction: In the clinical context, the results of this study indicate that disrupting the crosstalk between AT1R signaling and RAGE signaling can be an effective means to control Ang II-induced endothelial dysfunction and that sRAGE-mediated blockade of RAGE signaling has significant therapeutic potential.